| Product Code: ETC5259140 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Latvia`s colistin import market in 2024 continued to be dominated by key players China, India, Denmark, Netherlands, and Belgium. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market structure. Despite a strong compound annual growth rate (CAGR) of 9.87% from 2020 to 2024, there was a notable decline in growth from 2023 to 2024 at -34.6%. This suggests a potential slowdown in the market, requiring a closer look at factors influencing this shift in order to strategize effectively in the future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Colistin Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Colistin Market - Industry Life Cycle |
3.4 Latvia Colistin Market - Porter's Five Forces |
3.5 Latvia Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Latvia Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multi-drug resistant bacterial infections in Latvia |
4.2.2 Growing awareness about the effectiveness of colistin in treating severe infections |
4.2.3 Rising investments in healthcare infrastructure and facilities in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines governing the use of colistin |
4.3.2 Potential adverse effects and concerns related to antibiotic resistance |
4.3.3 Competition from alternative treatments and therapies |
5 Latvia Colistin Market Trends |
6 Latvia Colistin Market Segmentations |
6.1 Latvia Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Colistin Market Revenues & Volume, By API, 2021-2031F |
6.1.3 Latvia Colistin Market Revenues & Volume, By Premix, 2021-2031F |
6.1.4 Latvia Colistin Market Revenues & Volume, By Others, 2021-2031F |
6.2 Latvia Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Colistin Market Revenues & Volume, By Pig, 2021-2031F |
6.2.3 Latvia Colistin Market Revenues & Volume, By Chicken, 2021-2031F |
6.2.4 Latvia Colistin Market Revenues & Volume, By Other, 2021-2031F |
7 Latvia Colistin Market Import-Export Trade Statistics |
7.1 Latvia Colistin Market Export to Major Countries |
7.2 Latvia Colistin Market Imports from Major Countries |
8 Latvia Colistin Market Key Performance Indicators |
8.1 Number of reported cases of multi-drug resistant bacterial infections in Latvia |
8.2 Percentage of healthcare professionals recommending colistin for severe infections |
8.3 Investments in research and development of new colistin formulations |
9 Latvia Colistin Market - Opportunity Assessment |
9.1 Latvia Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Latvia Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Colistin Market - Competitive Landscape |
10.1 Latvia Colistin Market Revenue Share, By Companies, 2024 |
10.2 Latvia Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |